Retatrutide Before FDA Approval? Lilly Just Changed the Conversation
Podcast: On The Pen GLP-1 NewsPublished On: Tue Jun 09 2026
Description: Dave breaks down an unreported Expanded Access Pathway that Eli Lilly has quietly established for Retatrutide.
The note was deleted
The note was saved
Your message was sent